Free tool
FAERS Monitor: Citalopram Hydrobromide
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215428 or its brand name (Citalopram Hydrobromide, Citalopram Hydrobromide). Reports on generic versions are filed under their own applications.
Reports
107,749
Serious
88,370
82% of reports
Hospitalization
37,678
Death reported
17,192
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue7,087
- nausea6,075
- drug ineffective5,636
- headache5,236
- toxicity to various agents5,192
- diarrhoea4,873
- fall4,497
- pain4,483
- dizziness4,467
- off label use4,427
- completed suicide4,228
- dyspnoea4,187
- drug interaction4,178
- anxiety3,998
- vomiting3,836
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 803 |
| 2005 | 1,012 |
| 2006 | 1,091 |
| 2007 | 1,414 |
| 2008 | 2,043 |
| 2009 | 2,348 |
| 2010 | 2,849 |
| 2011 | 3,921 |
| 2012 | 4,855 |
| 2013 | 4,751 |
| 2014 | 5,906 |
| 2015 | 7,383 |
| 2016 | 7,684 |
| 2017 | 7,125 |
| 2018 | 8,132 |
| 2019 | 8,606 |
| 2020 | 7,289 |
| 2021 | 6,249 |
| 2022 | 5,329 |
| 2023 | 5,387 |
| 2024 | 5,021 |
| 2025 | 5,202 |
| 2026 | 3,346 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,946,410 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 4,228 | 10.4 | 10.1 | 34,145 |
| toxicity to various agentsSignal | 5,192 | 6.2 | 6.0 | 21,966 |
| drug interactionSignal | 4,178 | 5.3 | 5.1 | 14,109 |
| anxietySignal | 3,998 | 2.8 | 2.7 | 4,507 |
| fallSignal | 4,497 | 2.7 | 2.6 | 4,668 |
| fatigue | 7,087 | 1.8 | 1.7 | 2,512 |
| dizziness | 4,467 | 1.8 | 1.7 | 1,472 |
| headache | 5,236 | 1.6 | 1.6 | 1,321 |
| vomiting | 3,836 | 1.6 | 1.5 | 869 |
| nausea | 6,075 | 1.5 | 1.5 | 1,051 |
| diarrhoea | 4,873 | 1.5 | 1.4 | 769 |
| dyspnoea | 4,187 | 1.4 | 1.4 | 589 |
| pain | 4,483 | 1.4 | 1.4 | 587 |
| off label use | 4,427 | 1.0 | 1.0 | 1 |
| drug ineffective | 5,636 | 0.8 | 0.8 | 197 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.